Aerosol immunisation for TB: matching route of vaccination to route of infection
- PMID: 25636950
- PMCID: PMC4321022
- DOI: 10.1093/trstmh/tru206
Aerosol immunisation for TB: matching route of vaccination to route of infection
Abstract
TB remains a very significant global health burden. There is an urgent need for better tools for TB control, which include an effective vaccine. Bacillus Calmette-Guérin (BCG), the currently licensed vaccine, confers highly variable protection against pulmonary TB, the main source of TB transmission. Replacing BCG completely or boosting BCG with another vaccine are the two current strategies for TB vaccine development. Delivering a vaccine by aerosol represents a way to match the route of vaccination to the route of infection. This route of immunisation offers not only the scientific advantage of delivering the vaccine directly to the respiratory mucosa, but also practical and logistical advantages. This review summarises the state of current TB vaccine candidates in the pipeline, reviews current progress in aerosol administration of vaccines in general and evaluates the potential for TB vaccine candidates to be administered by the aerosol route.
Keywords: Aerosol; Tuberculosis; Vaccination; Vaccines.
© The Author 2015. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
References
-
- WHO. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.
-
- NICE. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Institute for Health and Care Excellence. 2011 - PubMed
-
- HPA. Tuberculosis in the UK. Health Protection Agency annual report. 2011. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Tuberculosis/ [accessed December 2014].
-
- Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677–86. - PubMed
-
- WHO. Multidrug and extensively drug-resistant TB (M/XDR TB):2010 global report on surveillance and response. Geneva: World Health Organization; 2010.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
